December 09, 2025
Projections indicate that, biosimilar contract manufacturing industry is projected to rise from USD 9.22 billion in 2025 to USD 52.23 billion by 2035, reflecting a CAGR of 18.94% over the next decade. The growing demand for cost-effective drugs and a...
December 22, 2025
Projections indicate that, biosimilars industry is projected to rise from USD 34.75 billion in 2024 to USD 175.79 billion by 2034, reflecting a CAGR of 17.6% over the next decade. In 2024, key advancements in biosimilars were made: CuraTeQ Biologics'...
December 12, 2025
The human insulin market is expanding steadily, rising from USD 20.97 billion in 2026 to USD 27.68 billion by 2035 at a CAGR of 3.13%, driven by increasing diabetes cases globally. This report covers complete segmentation by product, formulation, end...
November 01, 2025
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
November 26, 2025
Projections indicate that, the global ankylosing spondylitis market will increase from USD 6.7 billion in 2025 to USD 11.83 billion by 2035, experiencing a CAGR of 5.85% over the next 10 years. The rising prevalence of autoimmune disorders and growin...
November 01, 2025
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
November 01, 2025
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com